We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Meeting highlights from the Pharmacovigilance Risk Assessment Committee

News   Apr 15, 2013

 
Meeting highlights from the Pharmacovigilance Risk Assessment Committee
 
 
 

RELATED ARTICLES

Tech Behind Bitcoin Could Improve Medications of the Future

News

Researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

First Generic Version of EpiPen Is Approved

News

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE